Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence
What Is the Forecasted Market Size of the Nasal Corticosteroids Market by 2029?
The nasal corticosteroids market size has grown strongly in recent years. It will grow from $6.19 billion in 2024 to $6.70 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to increasing awareness about nasal corticosteroid treatments, growing incidence of chronic sinusitis, rising adoption of over-the-counter nasal sprays, increasing focus on outpatient care, and increasing availability of generic formulations.
The nasal corticosteroids market size is expected to see strong growth in the next few years. It will grow to $9.14 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to growing focus on non-invasive drug delivery, increasing investment in intranasal drug innovation, rising healthcare access in developing regions, growing demand for combination nasal therapies, and increasing e-commerce distribution for nasal medications. Major trends in the forecast period include advancement in intranasal delivery systems, advanced formulation of combination therapies, development of over-the-counter nasal corticosteroids, innovation in pediatric-friendly nasal sprays, and development of preservative-free nasal spray solutions.
Get your free report sample today:
What Are the Major Drivers Propelling the Growth of the Nasal Corticosteroids Market?
The increasing prevalence of respiratory diseases is expected to propel the growth of the nasal corticosteroids market going forward. Respiratory diseases refer to health problems that affect the lungs and make it hard to breathe, often causing coughing or shortness of breath. The increasing prevalence of respiratory diseases is due to rising air pollution and busy modern lifestyles characterized by exposure to harmful pollutants, smoking, and limited physical activity, which negatively impact lung health and increase the risk of breathing problems. Nasal corticosteroids help respiratory diseases by reducing swelling in the nasal passages, easing breathing, relieving symptoms such as congestion and sneezing, and improving overall airflow for better respiratory comfort. For instance, in June 2025, according to the Office for Health Improvement and Disparities, a UK-based government department, between the financial years ending 2023 and 2024, the rate of emergency admissions for respiratory diseases in England rose by 7%, with specific increases of 9% for COPD, 17% for adult asthma, and 16% for pneumonia. Therefore, the increasing prevalence of respiratory diseases is driving the growth of the nasal corticosteroids market.
How Is the Nasal Corticosteroids Market Structured Across Its Key Segment Categories?
The nasal corticosteroids market covered in this report is segmented –
1) By Product Type: Aqueous Nasal Sprays, Non-Aqueous Nasal Sprays
2) By Drug Type: Fluticasone Propionate, Budesonide, Beclomethasone Dipropionate, Mometasone Furoate, Triamcinolone Acetonide, Ciclesonide, Other Drug Types
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By Application: Allergic Rhinitis, Nasal Polyps, Sinusitis, Other Applications
5) By End-User: Hospitals, Clinics, Homecare Settings, Other End-Users
Subsegments:
1) By Aqueous Nasal Sprays: Metered-Dose Aqueous Nasal Sprays, Pump-Action Aqueous Nasal Sprays
2) By Non-Aqueous Nasal Sprays: Hydroalcoholic Nasal Sprays, Oil-Based Nasal Sprays
Which Disruptive Trends Are Reshaping the Competitive Landscape of the Nasal Corticosteroids Market?
Major companies operating in the nasal corticosteroids market are focusing on regulatory approval of innovative medications, such as exhalation delivery systems (EDS)-based nasal spray, to enhance drug delivery efficiency, improve treatment outcomes, and increase patient compliance. Exhalation delivery systems based on nasal spray refer to traditional nasal sprays that use the patient’s exhaled breath to close the soft palate and deliver medication high and deep into the nasal passages, improving drug deposition at inflamed sites. For instance, in May 2024, Optinose, Inc., a US-based pharmaceutical company, received FDA approval for XHANCE (fluticasone propionate) nasal spray as the first and only medication indicated for the treatment of adults with chronic rhinosinusitis without nasal polyps (CRSsNP). XHANCE utilizes a unique exhalation delivery system (EDS) technology to deliver corticosteroids deep into the nasal passages using a gentle exhalation, providing targeted anti-inflammatory action for chronic rhinosinusitis. This technology offers an alternative to traditional nasal sprays, which often have limited reach within the nasal cavity, by enabling effective medication delivery to hard-to-reach inflamed areas. XHANCE helps relieve nasal congestion and facial pressure associated with chronic rhinosinusitis without nasal polyps. It supports patients requiring long-term management of the condition while avoiding invasive procedures or the systemic side effects commonly associated with oral corticosteroids.
Which Companies Are Recognized as Major Innovators in the Nasal Corticosteroids Market?
Major companies operating in the nasal corticosteroids market are Pfizer Inc., Merck & Co Inc., Bayer AG, Sanofi S.A., GSK plc , Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Apotex Inc., Perrigo Company plc, Aurobindo Pharma Limited, Cipla Limited, Glenmark Pharmaceuticals Ltd, Alkem Laboratories Ltd, Pharmascience Inc., Mylan N.V, Aspire Pharma (UK), AdvaCare Pharma.
Get the detailed nasal corticosteroids market report today
Which Regional Markets Are Likely to See the Most Significant Expansion in the Coming Years?
North America was the largest region in the nasal corticosteroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nasal corticosteroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment